Lori-Ann Christie joined Visionary Venture Fund in 2021 as a principal where she identifies investment opportunities, conducts due diligence, and provides strategic guidance to companies…Read More
Dr. Nadia Waheed is Associate Professor in Ophthalmology at the Tufts University School of Medicine in Boston and Director of the Boston Image Reading Center.…Read More
Dr. David Sarraf is Clinical Professor of Ophthalmology at the Stein Eye Institute at UCLA and member of the Retinal Disorders and Ophthalmic Genetics Division.…Read More
Dr. Anupam Dalal is a Chief Investment Officer at Acuta Capital Partners LLC. He is responsible for managing healthcare investments, with a focus on biotech.…Read More
Andrew A. Moshfeghi, MD, MBA, earned his medical degree from Tulane University School of Medicine in 1999. Following the completion of his residency in ophthalmology,…Read More
Adrian is Chief Development Officer at jCyte, a clinical stage biotech company dedicated to preserving and restoring vision in patients with degenerative retinal disorders. Its…Read More
Carey Powers has more than 20 years of marketing leadership experience in the life sciences sector across a broad spectrum of verticals, including ophthalmology, aesthetics,…Read More
Chris Simms is Senior Vice President and Chief Commercial Officer of Iveric Bio. Mr. Simms is an accomplished healthcare leader with more than 20 years…Read More
Coming soon…Read More
Mary Beth Yackey, O.D. joined Cincinnati Eye Institute (CEI) in 2004. She provides patient care at three locations including Blue Ash, Ohio, Middletown, Ohio, and…Read More
Brianna Rhue earned her undergraduate degree from the University of Arizona before earning her Doctorate of Optometry at Nova Southeastern University. She completed her residency…Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.